Complete Genomics Denies Infringing Illumina's Patents; Claims They are Invalid or Unenforceable

Separately, the firm asked the court last month to move the case from the District of Delaware to the Northern District of California, "a more convenient venue."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.